- Investing Ideas
- Swedish Pharmaceuticals & Biotech Pure Equity Growth
Swedish Pharmaceuticals & Biotech Pure Equity Growth
Results
3
0 new
Companies that has zero debt on their balance sheet and is forecast to grow at an exponential rate in the future.
3 companies
Camurus
Market Cap: SEK 30.9b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 514.50
7D
-6.1%
1Y
-13.3%
BioArctic
Market Cap: SEK 26.6b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 314.00
7D
6.2%
1Y
78.5%
Bonesupport Holding
Market Cap: SEK 13.9b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 202.00
7D
-8.1%
1Y
-24.1%